With an annual dividend yield of 2.65%, CVS Health Corporation (NYSE:CVS) is included among the 12 High Yield Fortune 500 Stocks to Buy Now.

America’s leading health solutions company, CVS Health Corporation (NYSE:CVS), provides advanced health care from pharmacy services and health plans to health and wellness.

On June 8, Mizuho upped its price target on CVS Health Corporation (NYSE:CVS) from $110 to $115, and maintained its ‘Outperform’ rating on the shares. The revised target indicates an upside of over 14% from the current price level.

According to Mizuho, the managed care industry is going into a “more stable and predictable” policy backdrop. The analyst firm believes that the severity and frequency of policy-related surprises should ease down from the unusually high levels seen over the past three years. This should allow investors to focus on the company fundamentals, pricing recovery, and the underlying earnings potential of the overall sector.

As a result, Mizuho boosted its price targets across the managed care sector to reflect the more stable regulatory and legislative environment.

CVS Health Corporation (NYSE:CVS) has grown its dividends by 56.5% over the last decade and boasts an impressive annual yield of 2.65%. This makes it especially attractive for institutional investors and puts it among the 12 Best Dividend Stocks to Invest In According to Hedge Funds.

While we acknowledge the potential of CVS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 High Yield Crude Oil Stocks to Buy Now and 10 Most Volatile Stocks to Buy in S&P 500

Disclosure: None. Follow Insider Monkey on Google News.